Join Be The Match BioTherapies® and AABB® in San Antonio this fall for an interactive workshop and collaborative learning opportunity that will unpack real-world scenarios highlighting the challenges of implementing cellular therapies across various settings and business models.
The workshop will explore the perspectives of hospitals, blood centers and small startup companies with both centralized and decentralized manufacturing models. Join us for an afternoon of collaborative learning and deep discussion with world-renowned faculty.
Manufacturing Cellular Therapies: Challenges, Solutions and Creating Synergy for Success
Friday, Oct. 18, 2019
Grand Hyatt San Antonio
Texas Ballroom AB
San Antonio, Texas
Register for the workshop here.
Opening Session: Manufacturing Challenges in Implementing Cellular Therapy Services
This fireside chat will address the challenges and hurdles inherent to working in the cell and gene therapy industry. Participants will discuss successes, setbacks, and lessons learned as a result of sustained industry experience.
Magali Fontaine, MD, PhD
Amy Hines, RN, BSN
Joseph McGuirk, DO
Robert Tressler, PhD, MS
John McMannis, PhD
Plenary Session: Inroads to Response and Resistance in CAR-T Cell Therapy
Joseph Fraietta, PhD
Mechanisms of Tumor Escape from CAR-T Cell Therapy: Challenges and Solutions
The Therapeutic Use of Extracellular Vesicles by MSC: Improving Right Ventricular Function and Pulmonary Fibrosis with MSC Derived Exosomes
Breakout Session A: New Cells on the Block
This deep-dive session will highlight the latest scientific advancements in cellular-derived therapeutics, including exosomes, microparticles and emerging devices for delivery.
Magali Fontaine, MD, PhD
Patrick Hanley, PhD
Director, Cellular Therapy Laboratory
Presentation: Optimizing the Manufacture of MSCs and T cells for Phase 1 Clinical Trials
Aisha Khan, PhDc, MSc, MBA
Presentation: Pre-Clinical and Clinical Cell Manufacturing
Andrew Rhim, MD
Presentation: The Role of Blood Banks in Personalized Cancer Care
Breakout Session B: Ground-level Synergies for Novel Cell Therapies
This session will cover current strategies for donor selection, consent, and characterization as well as the latest advancements in the processing of source material for autologous and allogenic cell therapies.
Christie Malone, MT (ASCP) SBB
John Armitage, MD
Olive Sturtevant, MT(ASCP)SBB, CQA
Hanh Khuu, MD
Cellular Therapies Network Reception
Register today for the pre-meeting workshop, “Manufacturing Cellular Therapies: Challenges, Solutions and Creating Synergy for Success,” today!